| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/15/2004 | WO2004058288A1 Novel therapeutic targets in cancer |
| 07/15/2004 | WO2004058191A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | WO2004058190A2 Methods for treating taxol-induced sensory neuropathy |
| 07/15/2004 | WO2004058184A2 Anti-ngf antibodies and methods using same |
| 07/15/2004 | WO2004058183A2 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 07/15/2004 | WO2004058178A2 Uses of mammalian cytokine; related reagents |
| 07/15/2004 | WO2004058171A2 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | WO2004058167A2 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | WO2004058044A2 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 07/15/2004 | WO2004046190A3 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 07/15/2004 | WO2004042017A3 Methods and compositions for increasing antibody production |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004022713A3 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 07/15/2004 | WO2004003160A3 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003098190A3 Protein identification from protein product ion spectra |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003015694A3 Agents for enhancing the immune response |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002072141A8 Targeted ligands |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138428 Using modified chinese hamster ovaries which express cysteine protease, pepsin or serine protease activities to generate functional immunoglobulin fragments for use in mimetics and immunodiagnostics; enzyme inhibitors |
| 07/15/2004 | US20040138427 Chimeric monoclonal antibody for use as diagnostic and immunotherapeutic tool in treatment and prevention of infection, cancer, vascular, autoimmune, neurodegenerative and arthritic diseases; immunoassays |
| 07/15/2004 | US20040138426 Protein recovery |
| 07/15/2004 | US20040138421 ACPL DNA and polypeptides |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138162 Method of resisting osteoclast formation |
| 07/15/2004 | US20040138161 Methods of modulating proliferative conditions |
| 07/15/2004 | US20040138158 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138119 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
| 07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 07/15/2004 | US20040137935 Modular personal device system |
| 07/15/2004 | US20040137617 Purification of antigen-specific T cells |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137597 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137590 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137554 Diagnosis and treatment of bacterial infections |
| 07/15/2004 | US20040137535 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 07/15/2004 | US20040137534 Methods for detecting deantigenized T cell epitopes and uses thereof |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137514 Use of antibodies against specific mhc-peptide complexes |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137489 through comparative global WNT gene signaling antagonist expression profiling (soluble frizzled related protein 3 (SFRP-3/FRZB) or human homologue of Dickkopf-1 (DKK1)); gene expression inhibition |
| 07/15/2004 | US20040137482 Anti-microbial targeting chimeric pharmaceutical |
| 07/15/2004 | US20040137455 Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137438 Encoding transporter of the inner mitochondrial membrane; able to inhibit the expression of a MCF (mitochondrial carrier family) in a host cell in antisense orientation to a promoter; use in modification of transport properties |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040137000 deimmunized antibodies derived from mouse monoclonal antibody B4 |
| 07/15/2004 | US20040136998 Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen |
| 07/15/2004 | US20040136997 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 07/15/2004 | US20040136996 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136994 Methods of using CR3 and CR4 ligands for inhibiting interleukin-12 to treat autoimmune disease |
| 07/15/2004 | US20040136992 modulating inflammatory and immunoregulatory responses associated with cardiovascular disease with soluble receptor, fusion proteins, and/or antibodies of IL-17, IL-18 antagonist, 4-1BB, CD30 and OX40 |
| 07/15/2004 | US20040136991 Treatment of anemia using TNFalpha inhibitors |
| 07/15/2004 | US20040136990 Treatment of pain using TNFalpha inhibitors |
| 07/15/2004 | US20040136989 Kawasaki's Disease; Behcet's disease; TNF alpha antibody, or an antigen-binding fragment |
| 07/15/2004 | US20040136988 Treatment of schizophrenia |
| 07/15/2004 | US20040136987 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 07/15/2004 | US20040136986 Methods and compositions comprising glycoprotein glycoforms |
| 07/15/2004 | US20040136985 Methods of modifying behavior of CD9-expressing cells |
| 07/15/2004 | US20040136983 as anti-tumor agent or treating excessive vascular permeability; agonist for treating trauma to vascular network |
| 07/15/2004 | US20040136982 Novel monoclonal antibody |
| 07/15/2004 | US20040136980 Thrombopoietin(tpo) synthebody for stimulation of platelet production |
| 07/15/2004 | US20040136979 block, retard or reduce connective tissues regeneration; molecules released by catheters, surgical instruments or stents for angioplasty to prevent restenosis; atherosclerosis |
| 07/15/2004 | US20040136950 enhancing apoptosis induced by a TNF-family ligand, which involves administering to a cell that expresses the DR4 polypeptide an effective amount of an agonist capable of increasing DR4 mediated signaling |
| 07/15/2004 | US20040136908 Anti-cd19 immunotoxins |
| 07/15/2004 | CA2511967A1 Generation of immunoglobulin molecules with predetermined specificity |
| 07/15/2004 | CA2511959A1 Fc fusion |
| 07/15/2004 | CA2511910A1 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 07/15/2004 | CA2511598A1 Anti-ngf antibodies and methods using same |
| 07/15/2004 | CA2511295A1 Methods for treating taxol-induced sensory neuropathy |
| 07/15/2004 | CA2511245A1 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 07/15/2004 | CA2511013A1 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |